Posterior fossa ring-enhancing lesions in the adult immunocompetent host: illustrative cases, systematic review, and proposed diagnostic algorithm.
AuteursVan Boxstael E, de Hennin A, Vigneul E, Scoppettuolo P, El Sankari S, Bocchio AP, Borrelli S, Lolli V, van Pesch V, Slootjes SM, Finet P, Rovira À, Reich DS, Maggi P
Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial.
AuteursMetzger Filho O, Cardoso F, Poncet C, Desmedt C, Linn S, Wesseling J, Hilbers F, Delaloge S, Pierga JY, Brain E, Vrijaldenhoven S, Neijenhuis PA, Rutgers EJT, Piccart M, van 't Veer LJ, Viale G
Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study.
AuteursMaisonobe L, Korganow AS, Berti A, Deroux A, Dupin N, Aractingi S, Emmi G, Vandergheynst F, Fabre M, Kluger N, Roux M, Abisror N, Benyamine A, Cassone G, Chasset F, Doutre MS, Foucher A, Freguin C, Gobert D, Gombeir Y, Hernandez-Rodriguez J, Legouellec N, Pinault AL, Titeca D, Jachiet M, Terrier B
Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External Experts.
AuteursChernyshov PV, Finlay AY, Tomas-Aragones L, Poot F, Murrell DF, Pustisek N, Svensson A, Marron SE, Sampogna F, Bewley A, Salavastru C, Koumaki D, Suru A, Yordanova IA, Zemskov S, Tsymbaliuk R, Ostapko O, Augustin M, Abeni D, Szepietowski JC, Jemec GB
The Brussels consensus for non-invasive ICP monitoring when invasive systems are not available in the care of TBI patients (the B-ICONIC consensus, recommendations, and management algorithm).
AuteursRobba C, Picetti E, Vásquez-García S, Abulhasan YB, Ain A, Adeleye AO, Aries M, Brasil S, Badenes R, Bertuccio A, Bouzat P, Bustamante L, Calabro' L, Njimi H, Cardim D, Citerio G, Czosnyka M, Geeraerts T, Godoy DA, Hirzallah MI, Devi BI, Jibaja M, Lochner P, Mijangos Méndez JC, Meyfroidt G, Munusamy T, Portilla JP, Prabhakar H, Rasulo F, Sánchez Parra DM, Sarwal A, Shrestha GS, Shukla DP, Sung G, Tirsit A, Vásquez F, Videtta W, Wang YL, Paiva WS, Taccone FS, Rubiano AM
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
AuteursDaoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, Njimi H, Daxhelet M, Nobile L, Karama J, White JM, Jemec GBE, Del Marmol V
